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nonsmokers but not in the cannabis users and smokers. The 
groups did not differ with regard to task performance.  Con-
clusions: Our results suggest that regular cannabis use af-
fects certain aspects of motivation and that both tobacco 
smoking and cannabis use lead to similar motivational 
changes. However, the use of cannabis seems to affect 
motivation in a stronger way than does tobacco smoking 
alone.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Cannabis is one of the most commonly used illicit 
drugs, and its effects are often considered less harmful 
than the effects of other illicit drugs  [1] . However, recent 
work has showed that behavioral and physical cannabis 
dependence occurs in about 7–10% of regular users  [2] . 
Furthermore, regular cannabis use seems to be associat-
ed with adverse effects on health and with the develop-
ment or exacerbation of schizophrenia  [1, 2] . Addition-
ally, long-term heavy marijuana use is associated with 
impairment of memory, attention and decision-making 
 [3, 4] . However, the consequences of cannabis use on mo-
tivation in humans have not yet been investigated.
 There is a strong relationship between cannabis and 
tobacco use. When smoked, cannabis is mixed with to-
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 Abstract 
 Background: Cannabis is one of the most commonly used 
illicit drugs. Reduced neural and behavioral reactions to re-
ward have been demonstrated in other forms of addiction, 
as expressed by reduced mood reactivity and lack of striatal 
activation to rewards, but this effect has not yet been inves-
tigated in cannabis users.  Methods: We hypothesized that 
cannabis users and tobacco smokers would evidence lower 
positive mood ratings in rewarded conditions than control 
participants and that this reduction would be greater in can-
nabis users than in smokers. We examined the influence of 
reward on mood and performance in a group of regular can-
nabis users, a group of tobacco smokers and a group of non-
smokers while they performed a spatial recognition task 
with delayed response that incorporated 3 levels of difficul-
ty. Correct responses were either not reinforced or reinforced 
with money. We measured the accuracy of reactions, reac-
tion times and mood ratings throughout the trials.  Results: 
Cannabis users rated their mood as significantly worse than 
the smokers and nonsmokers during the easiest level of the 
rewarded condition. A significant positive correlation be-
tween mood ratings and monetary reward was found in the 
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bacco, so that the consumption of cannabis is often as-
sociated with tobacco smoking  [5] . Epidemiological stud-
ies showed that adolescents who smoked cigarettes were 
9–15 times more likely to use cannabis  [6, 7] . Recently, a 
reverse association between cannabis and tobacco was 
demonstrated. Due to the use of tobacco along with mar-
ijuana in joints  [8, 9] , cannabis use was shown to impede 
the users’ attempts to quit tobacco smoking and to in-
crease the risk of nicotine dependence  [8, 9] .
 The psychoactive substances contained in cannabis, 
i.e. delta-9-tetrahydrocannabinol (THC), and in tobacco, 
i.e. nicotine, both increase the dopamine (DA) transmis-
sion within the mesolimbic DA system, especially in the 
nucleus accumbens  [10–15] . This mechanism is thought 
to be one of the common denominators between all sub-
stances of abuse  [16–19] . Because the mesolimbic DA sys-
tem is involved in the processing of reward information, 
it has been postulated that the reinforcing properties of 
psychoactive drugs could be mediated by this system  [16–
19] . The cerebral reward system involves a neural circuit-
ry including, among others, the ventral striatum (nucleus 
accumbens), the amygdala and the orbitofrontal cortex 
 [20–26] , which also receives input from neurotransmit-
ters other than DA, such as opioid peptide, gamma-ami-
nobutyric acid and glutamate  [27, 28] . Some regions of the 
reward system, like the ventral tegmental area and the 
nucleus accumbens, are anatomically interconnected 
with endogenous brain opioid systems that have a modu-
latory influence on them  [29] . Another neurobiological 
mechanism common to addictive drugs is that opiate an-
tagonists block or attenuate the enhanced brain reward 
response produced by these drugs  [28, 29] . This effect was 
also demonstrated for THC. Animal studies showed that 
the opiate antagonist naloxone attenuated a THC-in-
duced DA increase in the nucleus accumbens  [14, 30, 31] 
and attenuated THC-enhanced DA synthesis  [32] . Final-
ly, opioid peptide antagonists significantly attenuated 
THC self-administration in rats and squirrel monkeys 
 [33, 34] . 
 Because substances of abuse affect reward mecha-
nisms at a neurobiological level, it can be hypothesized 
that substance users treat rewarding information in a dif-
ferent way than nonusers. Therefore, reward processing 
offers a promising way to investigate the effects of can-
nabis use on motivational processes.
 Reduced neural and behavioral reactions to reward 
have been demonstrated in smokers in previous positron 
emission tomography studies  [35, 36] . The difference be-
tween smokers and nonsmokers primarily involved brain 
regions belonging to the mesolimbic DA system, espe-
cially the striatum, which was not activated at all by rein-
forcement in smokers. At a behavioral level, these studies 
showed that, in contrast to the nonsmokers, reward did 
not improve the mood ratings of the smokers. Further-
more, there was no correlation between the amount of the 
reward and the mood ratings of smokers, in contrast to 
nonsmokers. These results suggest that reward does not 
elicit the same positive feelings in smokers as in non-
smokers, due to the changes in the cerebral reward sys-
tem induced by addiction. Similar results were found in 
a study of opiate addicts  [37] , leading to the conclusion 
that both types of addiction are associated with changes 
in the neural processing of reward. However, so far, no 
study has investigated the effect of regular cannabis use 
on reward processing, and the consequences of cannabis 
use on motivation are still unclear. 
 In this study, we investigated whether there was a re-
duced influence of monetary reward on the momentary 
mood, defined as the current subjective feelings of well-
being, in cannabis users compared to nonsmokers and 
smokers. We used a spatial recognition test with 3 diffi-
culty levels adapted from Glahn et al.  [38] . Because mon-
etary reinforcement has been shown to have a beneficial 
effect on performance in healthy participants  [39] , espe-
cially for easy tasks where increased effort can induce 
better performance  [40] , and because previous studies 
 [41] showed that smokers evaluated the effort associated 
with a reinforced memory task as significantly greater 
than did controls, we decided to include a task with dif-
ferent levels of difficulty in order to test the complex re-
lationship between reinforcement, difficulty and addic-
tion. We included a group of smokers to control for the 
effect of nicotine use, because cannabis users are mostly 
smokers. Since previous studies evidenced a positive ef-
fect of reward on mood state and because this effect was 
weakened in smokers  [35, 36] , we expected a similar but 
stronger effect in cannabis smokers. We also hypothe-
sized that cannabis users and tobacco smokers would dis-
play a reduction of the effect of monetary reward on 
mood when compared to control participants and that 
this reduction would be greater in cannabis users than in 
smokers. Furthermore, we expected the differences be-
tween the groups to be greater for the most difficult than 
for the easiest level of our task. More specifically, we ex-
pected no differences between the groups at the easiest 
level of difficulty, but we postulated that differences 
would emerge in the difficult conditions. Finally, we ex-
pected a significant association between mood ratings 
and monetary wins in the nonsmokers, but not in the to-
bacco smokers and cannabis users.
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 Methods 
 Participants 
 Fifty-three participants were included in the study: 19 non-
smokers, 20 smokers and 14 cannabis users. Subjects were recruit-
ed through advertisements at the University of Basel (Switzer-
land) and were all students. All subjects were right-handed. They 
were tested for neurological or medical disorders and for current 
medication with a short medical screening. Normal memory and 
attention performance were required for participation in the ex-
periment; these were tested prior to the trials using the Spatial 
Recall Test  [42] and the d2 test  [43] , respectively. There were no 
performance differences between the groups of participants for 
these tests (Spatial Recall Test: F 2, 50 = 0.55, p = 0.58; d2 total score 
of correct responses: F 2, 50 = 0.79, p = 0.54). Candidates with cur-
rent depression were excluded using the Beck Depression Inven-
tory (BDI) adapted from Beck et al.  [44] . There were no significant 
differences in the depression scores between the groups (F 2, 50 = 
1.17, p = 0.31). Current and past drug dependence as well as his-
tory or presence of psychiatric disorders were assessed using the 
ICD-10 Symptom Checklist  [45] . The severity of nicotine depen-
dence was assessed prior to the testing using the Fagerström ques-
tionnaire  [46] . We developed a questionnaire to assess cannabis 
use habits, which included items on the duration of cannabis use, 
number of joints smoked per week, time of the day when cannabis 
was used, use of other addictive substances and drug history. To 
be included in the study, smokers had to consume at least 10 ciga-
rettes per day and had to fulfill the ICD-10 criteria for nicotine 
dependence. They were excluded if they used any other substance 
of abuse, including cannabis, or had a past or current history of 
drug dependence other than nicotine dependence. Cannabis us-
ers had to consume cannabis at least 5 times a week. The cannabis 
subject group used cannabis an average of 5.7  8 0.7 (mean  8 SD) 
times per week, mostly in the evening. Of the 14 cannabis users, 
12 were regular smokers and 2 did not smoke, and none of them 
fulfilled the criteria for cannabis dependence or abuse according 
to ICD-10 criteria. They were excluded if they used any substance 
of abuse other than nicotine or cannabis and if they had a past or 
current history of drug dependence other than nicotine depen-
dence. They were instructed not to use cannabis on the day of the 
study. General exclusion criteria were current use of psychophar-
macological medication, current or past depression, history of 
psychiatric and neurological disorders as well as memory and at-
tention performance below the normal range. In addition, non-
smokers were excluded if they had past or current drug depen-
dence or had used any substance of abuse within the previous 
year. Sample demographics, including gender, age, years of educa-
tion and BDI and Fagerström scores, as well as the frequency and 
duration of smoking, are summarized in  table 1 . The subject 
groups did not differ with regard to age (F 2, 52 = 0.21, p = 0.80) or 
education (F 2, 52 = 0.27, p = 0.75).
 The participants were thoroughly informed about the study 
and gave written informed consent according to the Declaration 
of Helsinki.
 Experimental Task 
 The participants performed a spatial delayed response task 
adapted from Glahn et al.  [38] , which was primarily designed to 
investigate which brain regions reacted to the systematic increase 
of cognitive load. The task was programmed using E-Prime soft-
ware (version 1.1.3, Psychology Software Tools Inc., Pittsburgh, 
Pa., USA) and presented on a high-resolution color monitor (Sam-
sung SyncMaster P750). The monitor resolution was 1,024  ! 768 
pixels, and the presentation of the stimuli was synchronized with 
the refresh rate of the monitor. The display was viewed from a 
distance of 50 cm. The task comprised 3 levels of difficulty, which 
were differentiated by the number of items (3, 5 or 7) to be remem-
bered ( fig. 1 ). There were 2 feedback conditions: a rewarded and a 
baseline condition. All participants had to perform the task with 
the 3 levels of difficulty under the 2 feedback conditions. The or-
der of feedback conditions was counterbalanced across partici-
pants. During the rewarded condition, the participants could 
earn a monetary reward for every correct response. The monetary 
reward increased according to the difficulty of the task, i.e. CHF 
0.50 (approximately USD 0.40) in the block with 3 circles, CHF 1 
(approximately USD 0.80) in the block with 5 circles and CHF 2 
(approximately USD 1.60) in the block with 7 circles. Each level 
of difficulty comprised 12 trials. The participants were informed 
that they would receive the sum shown at the end of the trials. The 
maximum reward that could be won was CHF 42 (approximately 
USD 35). Before the main experiment started, participants under-
went a training phase in which they had to achieve at least 70% 
correct responses to proceed to the main task. The criterion of 
70% was chosen to prevent arbitrary guessing and thereby verify 
understanding of the task. 
 There was a break of 10 min between the 2 conditions, during 
which the smokers could smoke 1 cigarette before continuing the 
trials in order to avoid withdrawal symptoms that could affect 
mood during the second part of the experiment. All smokers used 
this possibility and smoked 1 cigarette during the break. 
Table 1. Sample demographics for our 3 groups of subjects
Nonsmokers Smokers Cannabis
users
Men, n (%) 10 (52.6) 10 (50) 8 (57.1)
Age, years 25.281.08 2681.6 24.681.3
Years of education 15.280.35 15.380.33 14.980.41
BDI score 3.681.01 3.7580.89 5.781.2
Fagerström scores – 4.680.35 3.3680.72
Cigarettes per day – 15.680.49 12.381.7
Years of cigarette use – 6.680.43 4.980.72
Cannabis joints per week – – 5.880.20
Years of cannabis use – – 2.580.25
Values shown are means 8 standard errors. There were no 
significant differences between the subject groups with regard to 
age, education or BDI scores. The smokers and cannabis users did 
not differ with regard to their Fagerström test scores. The BDI 
measures the severity of depression with 21 items. A score of 11 is 
considered to be the cutoff for clinical depression. The maximum 
score on the Fagerström test is 10. This test differentiates between 
the following levels of dependence: (1) low (0–2 points), (2) middle 
(3–5 points), (3) strong (6–7 points) and (4) very strong (8–10 
points).
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 Rating of Mood and Monetary Wins 
 The participants were asked to rate their momentary mood on 
a scale from 1 (bad) to 5 (good) at baseline, at the beginning of the 
experimental session and after each difficulty block in each con-
dition. In order to control for differences in the evaluation of the 
monetary earning between the groups of participants, we asked 
them to rate the value of the amount of money they had won on a 
scale from 0 (no value) to 10 (high value). Furthermore, the par-
ticipants were asked at the end of the testing session to rate how 
strenuous the task was for them.
 Data Analysis 
 Baseline mood ratings were compared among the groups us-
ing a 1-factor analysis of variance (ANOVA). If we did not find 
any significant group differences at baseline, these ratings were 
not integrated into the further analyses of mood. In order to test 
our main hypothesis, i.e. that there is a reduced influence of re-
ward on mood states in smokers and cannabis users that is more 
accentuated in the most difficult level of a task, we performed an 
ANOVA for repeated measures using mood as a dependent vari-
able, with the 3 following factors: groups of participants (non-
smokers, smokers and cannabis users), feedback conditions (re-
warded and not rewarded) and levels of difficulty. The level of 
difficulty yields indirect information about the influence of the 
monetary gain on mood for each level of difficulty, since level of 
difficulty and monetary reward are strongly correlated (non-
smokers: r = 0.89; smokers: r = 0.89; cannabis users: r = 0.91). In 
addition, we postulated that there would be a significant positive 
correlation between mood ratings and monetary wins in the re-
warded conditions in the nonsmokers, but not in the smokers or 
Account:
X CHF
Feedback
or mask
1,500 ms
+
+
+
+
Target
3,000 ms
Reaction
Fixation
3,000 ms
Display
2,000 ms
Fixation
500 ms
 Fig. 1. Schematic representation of a trial of the spatial delayed 
recall task. In the first display, an array of yellow circles (3, 5 or 7) 
was presented for 2,000 ms after a fixation time of 500 ms. After 
a delay of 3,000 ms, a green circle appeared and the subject had 
1,500 ms to decide whether the position of the green circle was the 
same as that of one of the preceding yellow circles. If so, the cor-
rect response for the participants was to press a button with their 
right hand. If not, the participants had to press a button with their 
left hand. After the response time had elapsed, the circle disap-
peared and the accumulated amount of money earned appeared 
on the screen (in the rewarded condition) or the screen remained 
blank (in the unrewarded condition). The positions of the circles 
varied randomly and were organized according to a 5  ! 5 grid 
dividing the space into 25 possible positions. The task comprised 
3 levels of difficulty determined by the number of circles to re-
member. During the rewarded condition, the participants could 
earn a monetary reward for every correct response. The monetary 
reward increased according to the difficulty of the task.  
Group n Difficulty 
(number
of circles)
Rewarded conditions Unrewarded conditions
mood scoremood score monetary 
win, CHF
Nonsmokers 19 3 3.6880.20 5.3980.16 3.6880.23
5 3.4280.26 9.4780.40 3.6880.23
7 3.3680.24 15.8980.76 3.2680.24
Smokers 20 3 3.8080.20 5.4380.12 3.5580.21
5 3.5580.21 9.1080.46 3.5080.18
7 3.2080.22 15.8080.65 3.280.18
Cannabis
users
14 3 2.9280.37 5.2980.18 3.1480.29
5 2.9280.32 9.1480.52 3.1480.31
7 3.2180.32 17.1480.72 3.2880.30
The subjects did not differ with regard to their monetary wins. The cannabis users 
evidenced lower mood scores than both the smokers and the nonsmokers at the easiest 
level of difficulty of the rewarded conditions at a significance level that did not survive 
Bonferroni correction, but did show a trend (p < 0.05). Mood scores: 1 = bad mood; 5 = 
good mood. Maximum reward: CHF 6 in the 3-circle condition, CHF 12 in the 5-circle 
condition and CHF 24 in the 7-circle condition.
Table 2. Means and standard errors for 
the amount of received monetary reward, 
and mood scores in the rewarded and un-
rewarded conditions, for each level of dif-
ficulty of the task
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cannabis users. To test this hypothesis, we used Pearson product-
moment correlation and analyzed each group of subjects sepa-
rately. Two additional ANOVAs for repeated measures were ap-
plied using response accuracy and reaction time as dependent 
variables with the same 3 factors as listed above, in order to test 
the effect of reward on performance and to control for possible 
performance differences among the groups of participants. The 
evaluation of the value of the monetary reward, as well as the rat-
ings of the effort associated with the task, were analyzed using an 
ANOVA with 1 factor, i.e. the groups of subjects, and the rated 
value of the monetary gain, or the effort ratings, as the dependent 
variable. In order to account for multiple comparisons, we used 
Bonferroni tests as post hoc tests for the one-way ANOVAs and 
Bonferroni-corrected significance levels for the post hoc tests 
(t tests) of the ANOVAs with repeated measures. The Bonferroni-
corrected significance level was set separately for each analysis 
using the following formula: 1 – (1 –   ) 1/n  , where n is the number 
of possible comparisons of interest to test the hypothesis accord-
ing to the Holm-Bonferroni method  [47] . 
 Results 
 Reward and Mood  
 The average mood scores in the rewarded and unre-
warded conditions are summarized in  table 2 . Baseline 
mood scores were 4.15  8 0.68 (mean  8 SD) for the non-
smokers, 3.95  8 0.60 for the smokers and 3.64  8 0.92 for 
the cannabis users. The results of the 1-factor ANOVA 
showed no significant difference in mood between the 
groups at baseline (F 2, 50 = 2, p = 0.14).
 The 3-factor ANOVA of mood showed a significant 
effect only for the interaction between groups and levels 
of difficulty (F 4, 100 = 2.44, p  ! 0.05). Neither the main ef-
fects for the factors reward (F 1, 50 = 0.18, p = 0.66), diffi-
culty (F 2, 100 = 2.34, p = 0.10) and group (F 2, 50 = 1.07, p = 
0.35) nor the interactions between difficulty and reward 
(F 2, 100 = 0.92, p = 0.40), between group and reward (F 2, 
100 = 0.69, p = 0.50) and between difficulty, group and re-
ward (F 4, 100 = 0.75, p = 0.55) reached significance. Subse-
quent post hoc tests did not evidence any results that sur-
vived the Bonferroni-corrected significance level of 0.016 
(corresponding to   = 0.05 with 3 comparisons of inter-
est) for the comparison of mood between the rewarded 
and the unrewarded conditions, when each group of sub-
jects was analyzed separately. Using subsequent indepen-
dent-sample t tests, we found group differences that 
showed a trend at the Bonferroni-corrected significance 
level of 0.01 (corresponding to   = 0.05 with 9 compari-
sons of interest) in the rewarded 3-circle condition. The 
cannabis users evidenced lower mood scores than both 
the smokers (t 32 = –2.23, p  ! 0.04) and the nonsmokers 
(t 31 = –1.91, p  ! 0.06) in this condition ( fig. 2 ). The cor-
relation analyses between mood ratings and monetary 
wins showed significant results in the easy and middle 
levels of difficulty [3 circles: r 19 = 0.48, p  ! 0.05 ( fig. 3 ); 5 
circles: r 19 = 0.60, p  ! 0.01] and a trend for the most dif-
ficult level (7 circles: r 19 = 0.42, p  ! 0.07) in the nonsmok-
er subjects, but no significant results were found in the 
1
3
circles
*
5
circles
7
circles
3
circles
5
circles
7
circles
Rewarded Unrewarded
Conditions
M
oo
d
 s
co
re
2
3
4
5
Nonsmokers
Smokers
Cannabis users
 Fig. 2. Mean mood scores at the different 
levels of difficulty and conditions of rein-
forcement for each group of participants. 
Mood was significantly lower in cannabis 
users than in smokers and nonsmokers, at 
a significance level that did not survive 
Bonferroni corrections for multiple com-
parisons (p  ! 0.05), but did show a trend. 
Only the mood scores rated during the ex-
perimental conditions are presented, be-
cause the subjects did not differ in their 
baseline mood ratings.  * p  ! 0.05. Mood 
scores: 1 = bad mood; 5 = good mood.
Dotted line = Comparison showing a trend 
at p  ! 0.06 . 
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smoker subjects (3 circles: r 20 = 0.34, p = 0.13; 5 circles: 
r 20 = 0.32, p = 0.16; 7 circles: r 20 = 0.34, p = 0.14) or in the 
group of cannabis users (3 circles: r 14 = –0.18, p = 0.53; 5 
circles: r 14 = 0.46, p  ! 0.09; 7 circles: r 14 = –0.22, p = 0.43). 
To test whether these correlation coefficients were sig-
nificantly different between the groups of subjects, we 
transformed the coefficients with the Fisher Z transfor-
mation and found a trend in the comparison between the 
nonsmoker group and the group of cannabis users at the 
easiest level of difficulty (p = 0.07).
 As a control measurement, we compared the amount 
of money earned by the participants in each group using 
a 1-factor ANOVA and did not find any difference be-
tween the groups (F 2, 50 = 0.351, p = 0.70). The ANOVA of 
the value of monetary earnings at the end of the experi-
ment also showed no difference between the groups of 
participants (F 2, 50 = 1.05, p = 0.35). However, the rating 
of the effort associated with the experiment showed group 
differences (F 2, 50 = 3.22, p  ! 0.05), expressed by lower 
ratings in cannabis users than in smokers (p  ! 0.05) and 
lower ratings in smokers than in nonsmokers (p  ! 0.05).
 Reward and Performance 
 The results for reaction accuracy and reaction time for 
each level of difficulty are summarized in  table 3 . 
 The 3-factor ANOVA of reaction accuracy showed a 
significant effect only for the factor difficulty (F 2, 100 = 
90.35, p  ! 0.001). Neither the main effects for the factors 
reward (F 1, 50 = 0.172, p = 0.68) and group (F 2, 50 = 0.092, 
p = 0.91) nor any of the interactions tested, including the 
interaction between difficulty and reward (F 2, 100 = 2.51, 
p = 0.08), between group and reward (F 2, 100 = 0.58, p = 
0.56), between difficulty and group (F 4, 100 = 0.51, p = 
0.72) and between difficulty, group and reward (F 4, 100 = 
0.71, p = 0.58) reached significance.
 The analogous ANOVA of reaction times yielded 
slightly different results; the main effects for the reward 
(F 1, 50 = 108.06, p  ! 0.001) and difficulty (F 2, 100 = 18.98, 
p  ! 0.001) factors, as well as the interaction between the 
two (F 2, 100 = 3.91, p  ! 0.05), were significant. However, the 
group factor did not yield any significant results (main ef-
fect: F 2, 50 = 0.13, p = 0.87; interaction between group and 
reward: F 2, 50 = 0.55, p = 0.58; interaction between group 
and difficulty: F 4, 100 = 1.18, p = 0.32; interaction between 
group, difficulty and reward: F 4, 100 = 0.78, p = 0.53). 
 Subsequent post hoc tests evidenced significant results 
that survived the Bonferroni-corrected significance level 
of 0.016 (corresponding to   = 0.05 with 3 comparisons 
of interest) in all comparisons between the rewarded and 
unrewarded conditions in each group of subjects. The re-
action times were significantly higher in the unrewarded 
conditions than in the rewarded conditions for all levels 
of difficulty (lowest t value: t 19 = 3.07, p  ! 0.006). 
 A significant increase in reaction times over the 3 lev-
els of difficulty was evidenced only in the unrewarded 
conditions. In the smoker group, this increase was sig-
0
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 Fig. 3. Correlations between the mean mood scores and the 
amount of monetary reward received during the task’s easiest lev-
el of difficulty (3 circles). The comparison of the correlation coef-
ficients showed a trend between the nonsmoker group and the 
group of cannabis users (p = 0.07). Because in each group of sub-
jects, several subjects showed the same association between mood 
ratings and monetary wins, they are represented as clouds or 
groups of subjects ( j ) and not as single cases. This is associated 
with a reduced variance of the data that might influence the re-
sults.  a For the nonsmokers (n = 19) there was a significant posi-
tive correlation between mood scores and monetary reward.  b For 
the smokers (n = 20) there was no significant correlation.  c The 
cannabis users (n = 14) also showed no significant correlation. 
Mood scores: 1 = bad mood; 5 = good mood. 
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nificant at a Bonferroni-corrected significance level of 
0.016 (corresponding to   = 0.05 with 3 comparisons of 
interest) between all the levels of difficulty (lowest t value: 
t 19 = –3.11, p  ! 0.006). In the nonsmoker group, this in-
crease was significant only in the comparison between 
the 3-circle and 7-circle conditions (t 18 = –4.39, p  ! 0.001). 
In the group of cannabis users, this increase was signifi-
cant only in the comparison between the 3-circle and 5-
circle conditions (t 13 = –2.75, p  ! 0.016). 
 In summary, these results confirm that monetary re-
inforcement, as well as the level of difficulty, influenced 
specific aspects of performance, i.e. reaction times, in a 
similar way in all groups of participants and that there 
were no performance differences between the groups of 
participants.
 Discussion 
 The main aim of the present study was to investigate 
whether cannabis use influenced the effect of a monetary 
reward on mood ratings. We hypothesized that cannabis 
users and tobacco smokers would show a reduction in the 
effect of a monetary reward on mood ratings compared 
to control participants and that this reduction would be 
greater in cannabis users than in smokers. We used a spa-
tial delay task including 3 levels of difficulty in order to 
test the relationship between reinforcement, effort and 
addiction. We expected the group differences to be great-
er for the most difficult than for the easiest conditions of 
our task. 
 Our results indicate a reduced influence of monetary 
reward on momentary mood ratings in cannabis users. 
However, contrary to our hypothesis, this effect was 
found in the easiest condition of our task rather than in 
the most difficult. At the easiest level of difficulty of the 
rewarded condition, the cannabis users rated their mo-
mentary mood as significantly lower than the smokers 
and nonsmokers. These results are in contradiction with 
our hypothesis but are in agreement with the conclusions 
of Camerer and Hogarth  [40] that a monetary reward 
principally influences easy tasks. In addition, our results 
support the hypothesis of a positive correlation between 
monetary wins and mood ratings in the group of non-
smokers that was not significant in the group of cannabis 
users or tobacco smokers. Taken together, these results 
suggest, on the one side, a reduced association between 
mood and reward in the groups of substance users and, 
on the other side, a reduced effect of reward on mood in 
cannabis users only.
 The nonsignificant association between mood ratings 
and reward in the group of smokers is in agreement with 
Table 3. Means and standard errors for reaction accuracy and reaction time during the spatial delayed recall 
task
Group n Difficulty 
(number of 
circles)
Rewarded conditions Unrewarded conditions
correct responses, n reaction time, ms correct responses, n reaction time, ms
Non-smokers 19 3 10.7980.32 933.33835.14 10.3280.32 1,055.52851.59
5 9.4780.40 968.64842.51 9.9580.36 1,122.71857.53
7 7.9580.38 1,008.75851.86 8.0580.47 1,192.14853.02
Smokers 20 3 10.8580.24 920.83845.46 10.680.22 1,025.18855.67
5 9.1080.46 952.74851.89 9.7080.36 1,098.85854.2
7 7.9080.32 967.38853.04 7.8080.40 1,208.48871.82
Cannabis users 14 3 10.5780.36 940.05835.25 10.580.37 1,097.98851.47
5 9.1480.52 979.66850.99 9.3680.41 1,204.65861.09
7 8.5780.36 976.02850.54 7.5080.59 1,180.85844.91
Accuracy is measured as the number of correct responses, with a maximum of 12 correct responses for each 
block. Significant results were found in all comparisons between the rewarded and the unrewarded conditions 
in each group of subjects. The reaction times were significantly higher in the unrewarded conditions than in 
the rewarded conditions for all levels of difficulty (lowest p value: <0.01). Significant increases in reaction times 
between the 3 levels of difficulty were evidenced only in the unrewarded conditions as follows: (1) smokers: 
significant increase between all levels of difficulty (lowest p value: <0.01); (2) nonsmokers: significant increase 
only in the comparison between the 3-circle and 7-circle conditions (t18 = –4.39, p < 0.001); (3) cannabis users: 
significant increase only in the comparison between the 3-circle and 5-circle conditions (p < 0.05).
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previous findings in smokers that showed reduced be-
havioral and neural reactions to reward  [35, 36] . These 
observations were explained by drug-induced dysfunc-
tion of the cerebral reward system, which led to a lack of 
activation of the striatum in response to reward. This ex-
planation is supported by the fact that striatal activation 
has been shown to correlate positively with reward-in-
duced mood changes  [36] as well as with amphetamine-
induced feelings of euphoria  [48, 49] . Our results are in 
agreement with current neurobiological theories which 
postulate that addiction is associated with persistent 
changes in motivation and in brain motivational systems 
 [50] . More specifically, it is hypothesized that there is a 
molecular or cellular neuroadaptation within the neural 
reward circuitry that compensates for the overactivity of 
hedonic feelings associated with addiction or repeated 
drug intake and finally results in a decrease in reward 
function. The emotional dysregulation accompanying 
withdrawal symptoms is also associated with a decreased 
reward function, an enhanced sensitization for drug 
stimuli and a reduced response to natural rewards  [51] 
that is thought to be related to the activation of an anti-
reward system  [50] . The neural correlates for this emo-
tional dysregulation are thought to be partly similar to 
the ones underlying anxiety and involve the extended 
amygdala  [52] , a neuroanatomical entity that is thought 
to integrate brain arousal stress systems with hedonic 
processing systems  [50] . The extended amygdala is an an-
atomically and neurochemically interconnected system 
in the basal forebrain consisting of the bed nucleus of the 
stria terminalis, the central nucleus of the amygdala and 
the shell of the nucleus accumbens  [53] . Taking drugs to 
alleviate the negative effects associated with withdrawal 
works as a negative reinforcer. This negative reinforce-
ment mechanism is thought to underlie the shift from 
regular drug use to compulsive drug use  [54] .
 Because the smokers in our study could smoke before 
and during the experiment, our results were not influ-
enced by the mood changes associated with withdrawal. 
However, prolonged exposure to drugs causes long-term 
neuronal and behavioral changes, including increased 
anxiety that involves noradrenergic and corticotrophin-
releasing factor transmission  [55] , which could explain 
the lack of association between reward and mood in 
smokers. Interestingly, this finding held true even for our 
group of modestly addicted smokers. 
 Similar results were evidenced in the cannabis users, 
suggesting that cannabis use affects reward processing at 
a behavioral level. This could be explained by a similar 
dysfunction of the brain motivational systems, especially 
of the extended amygdala, in cannabis users as in smok-
ers, and could indicate that cannabis use affects motiva-
tion, and that different substances of abuse elicit similar 
motivational changes at a behavioral level. The high den-
sity of cannabinoid receptors observed in regions in-
volved in emotional regulation, such as the amygdala, as 
well as the anxiolytic effects associated with enhance-
ment of endocannabinoid signaling, corroborate this hy-
pothesis  [56] . Furthermore, neuroimaging studies in hu-
mans showed a direct influence of THC on the amygdala 
response to emotional stimuli  [57, 58] . 
 In addition to the lack of a significant positive asso-
ciation between monetary wins and mood ratings, the 
group of cannabis users also showed lower mood ratings 
in response to monetary rewards than tobacco smokers 
and nonsmokers, suggesting that cannabis use more 
strongly affects the relationship between reward and 
mood than does tobacco use. This could be related to re-
duced emotional regulation in cannabis users, as suggest-
ed in a study by Dorard et al.  [59] , who reported higher 
anhedonia and alexithymia scores in cannabis users than 
in healthy controls. The most frequent reasons for can-
nabis use are related to enhancement of affective states 
 [60, 61] , including relaxation, an increase in pleasure and 
being high, thus supporting the hypothesis of impaired 
emotional regulation in cannabis users. Because the 
group differences were specific for one particular condi-
tion of the task, and because there were no group differ-
ences in baseline mood ratings, these findings cannot be 
explained by a generally lower mood in cannabis users. 
 The mood differences observed between cannabis us-
ers, tobacco smokers and nonsmokers also cannot be ex-
plained by differences in the task performance. Thus, re-
ward had the same effect on the performance of all par-
ticipants, which consisted of decreased reaction times in 
the rewarded trials when compared to the unrewarded 
trials. This finding is consistent with the meta-analytical 
study of Jenkins et al.  [39] , in which the authors conclud-
ed that reward enhances performance, especially in re-
gard to quantitative aspects. Furthermore, the reaction 
times were slower at the more difficult levels of the tasks 
than at the easiest ones for all groups of subjects in the 
unrewarded conditions only. The effect of increased work-
ing memory load on performance is consistent with the 
results of Glahn et al.  [38] obtained with the original ver-
sion of the task used in this study. Interestingly, no similar 
effect was found in the rewarded condition, suggesting 
that reward can attenuate the effect of increased cognitive 
effort on performance. These results did not confirm our 
hypothesis of a stronger effect of effort in the groups of 
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substance users, since the findings were the same in the 
groups of substance users and healthy controls. 
 The use of only one scale for the assessment of mo-
mentary mood states is certainly a limitation of the pres-
ent study, and we are aware that a single-item scale might 
not be sensitive enough to capture subtle mood changes 
over time. However, a more extensive assessment of mood 
would have delayed the time between the presentation of 
the monetary reward and the mood ratings. Further-
more, we assessed baseline mood ratings prior to the ex-
periment and did not find any group differences. The fact 
that the groups of subjects did not differ in their baseline 
mood ratings, but differed then in their mood ratings in 
response to reward, suggests that these changes are elic-
ited by the experimental conditions. Because several sub-
jects showed the same association between their mood 
ratings during the easiest experimental condition and 
their monetary wins for this condition, the data consid-
ered in the correlation analysis showed a reduced vari-
ance that might have affected the results. Another limita-
tion of the study is the lack of biological tests for the con-
trol of urine THC levels. Since the cannabis users needed 
to consume cannabis at least 5 times a week in order to 
be included in the study, these tests would have been pos-
itive in all cases. They would have given little information 
on whether the participants were under the influence of 
cannabis during the experiment. Furthermore, smoker 
subjects were allowed to smoke before and during the ex-
periment in order to avoid negative feelings associated 
with withdrawal. Therefore, the results could be inter-
preted as a direct effect of nicotine or cannabis use. How-
ever, since our results show differences between tobacco 
smokers and cannabis users, and because these results 
were in agreement with the results of previous studies, it 
can be postulated that they are related to changes induced 
by the regular use of these psychoactive substances and 
not by their direct psychopharmacological effect.
 In conclusion, our results indicate a reduced effect of 
reward on positive mood states in cannabis users. Since a 
similar result was observed in the group of smokers, this 
suggests that both substances of abuse lead to similar mo-
tivational changes. However, the use of cannabis seems to 
affect mood ratings in a stronger way than tobacco smok-
ing alone. Finally, these results suggest that regular can-
nabis use affects certain aspects of motivation.
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